Other Routes of Protein and Peptide Delivery: Transdermal, Topical, Uterine, and Rectal - Challenges in Delivery of Therapeutic Genomics and Proteomics - page 659

[66] Kumar S, Char H, Patel S, Piemontese D, Iqbal K, Malick AW, et al. Effect of iontopho-
resis on in vitro skin permeation of an analogue of growth hormone releasing factor in
the hairless guinea pig model. J Pharm Sci 1992;81:635-9.
[67] Stephen RL, Petelenz TJ, Jacobsen SC. Potential novel methods for insulin administra-
tion: I. Iontophoresis. Biomed Biochim Acta 1984;43:553-8.
[68] Kari B. Control of blood glucose levels in alloxan-diabetic rabbits by iontophoresis of
insulin. J Am Diabetes Assoc 1986;35:217-21.
[69] Meyer BR, Katzeff HL, Eschbach JC, Trimmer J, Zacharias SB, Rosen S, et al.
Transdermal delivery of human insulin to albino rabbits using electrical current. Am J
Med Sci 1989;297:321-5.
[70] Siddiqui O, Sun Y, Liu JC, Chien YW. Facilitated transdermal transport of insulin.
J Pharm Sci 1987;76:341-5.
[71] Liu JC, Sun Y, Siddiqui O, Chien YW. Blood glucose control in diabetic rats by transder-
mal iontophoretic delivery of insulin. Int J Pharm 1988;44:197-204.
[72] Srinivasan V, Higuchi WI, Sims SM, Ghanem AH, Behl CR. Transdermal iontophoretic
drug delivery: mechanistic analysis and application to polypeptide delivery. J Pharm Sci
1989;78:370-5.
[73] Sun Y, Xue H. Transdermal delivery of insulin by iontophoresis. Ann N Y Acad Sci
1991;618:596-8.
[74] Zakzewski CA, Wasilewski J, Cawley P, Ford W. Transdermal delivery of regular insulin
to chronic diabetic rats: effect of skin preparation and electrical enhancement. J Control
Release 1998;50:267-72.
[75] Kanikkannan N, Singh J, Ramarao P. Transdermal iontophoretic delivery of bovine insu-
lin and monomeric human insulin analogue. J Control Release 1999;59:99-105.
[76] Rastogi SK, Singh J. Passive and iontophoretic transport enhancement of insulin through
porcine epidermis by depilatories: permeability and Fourier transform infrared spectros-
copy studies. AAPS PharmSciTech 2003;4:29.
[77] Langkjaer L, Brange J, Grodsky GM, Guy RH. Iontophoresis of monomeric insulin
analogues in vitro : effects of insulin charge and skin pretreatment. J Control Release
1998;51:47-56.
[78] Clancy MJ, Corish J, Corrigan OI. A comparison of the effects of electrical current and
penetration enhancers on the properties of human skin using spectroscopic (FTIR) and
calorimetric (DSC) methods. Int J Pharm 1994;105:47-56.
[79] Riviere JE, Moteiro-Riviere NA, Rogers RA, Bommannan D, Tamada JA, Potts RO.
Pulsatile transdermal delivery of LHRH using electroporation: drug delivery and skin
toxicology. J Control Release 1995;36:229-33.
[80] Denet AR, Ucakar B, Preat V. Transdermal delivery of timolol and atenolol using electro-
poration and iontophoresis in combination: a mechanistic approach. Pharm Res 2003;20:
1946-51.
[81] Prausnitz MR. Overcoming skin's barrier: the search for effective and user friendly drug
delivery. Diabetes Technol Ther 2001;3:233-6.
[82] Prausnitz MR. Microneedles for transdermal drug delivery. Adv Drug Deliv Rev
2004;56:581-7.
[83] Bramson J, Dayball K, Evelegh C, Wan YH, Page D, Smith A. Enabling topical immuni-
zation via microporation: a novel method for pain-free and needle-free delivery of adeno-
virus-based vaccines. Gene Ther 2003;10:251-60.
[84] Levy D, Kost J, Meshulam Y, Langer R. Effect of ultrasound on transdermal drug deliv-
ery to rats and guinea pigs. J Clin Invest 1989;83:2074-8.
[85] Tyle P, Agrawala P. Drug delivery by phonophoresis. Pharm Res 1989;6:355-61.